Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | H240 - Building for Success—Creating a Team to Lead and Excel in Clinical Trials (Academic Hub)

Wednesday 04/17/24
03:30 PM - 04:15 PM MDT Add To Calendar
Colorado Convention Center | Mile High 1A
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Hubs (Academic)
James D. Berry, MD MPH
Education, Research, and Methodology
This course will describe the process and importance of building and maturing a clinical research team to conduct high quality clinical trials.  The talk will draw from personal experiences (successes at pitfalls) to illustrate the process of building and developing a research team.
No CME available

Program Materials Program Evaluations

Event Timeline
03:30 PM - 04:00 PM MDT Speaker Building for Success—Creating a Team to Lead and Excel in Clinical Trials
James D. Berry, MD MPH
Faculty Disclosures
James D. Berry, MD MPH Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene Nanomedicine. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma Holdings of America. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Berry has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Berry has stock in ReactNeuro. The institution of Dr. Berry has received research support from Biogen. The institution of Dr. Berry has received research support from MT Pharma of America. The institution of Dr. Berry has received research support from Rapa Therapeutics. The institution of Dr. Berry has received research support from Brainstorm Cell Therapeutics. The institution of Dr. Berry has received research support from Alexion. The institution of Dr. Berry has received research support from nQ Medical. The institution of Dr. Berry has received research support from ALSA. The institution of Dr. Berry has received research support from MDA. The institution of Dr. Berry has received research support from Amylyx. The institution of Dr. Berry has received research support from Transposon. Dr. Berry has a non-compensated relationship as a Scientific Advisor with Everything ALS that is relevant to AAN interests or activities.